InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+1.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Sigal Charles Elliott, Director. Director active across 3 companies, notably Vir Biotechnology, Inc.. In total, 11 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €172k. Activity tracked since 21 May 2021. The latest transaction was filed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sigal Charles Elliott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
671 shares0Common StockSEC:0001178670-26-000042:0
8,000 shares0Common StockSEC:0001628280-25-028902:0
775 shares0Common StockSEC:0001735276-25-000060:0
8,000 shares0Common StockSEC:0001628280-24-026221:0
45,453 sharesCommon StockSEC:0001209191-23-048762:0
6,027 shares0Common StockSEC:0001209191-23-031840:0
2,500 shares@ US$22.726231.1% of flowCommon StockSEC:0001209191-23-014673:0
Canonical exit: 30 May 2023 (T+90)
2,500 shares@ US$24.958234.1% of flowCommon StockSEC:0001209191-23-002507:0
Canonical exit: 5 Apr 2023 (T+90)
2,500 shares@ US$25.59734.7% of flowCommon StockSEC:0001209191-23-001932:0
Canonical exit: 3 Apr 2023 (T+90)
6,405 shares0Common StockSEC:0001209191-22-031959:0
3,374 shares0Common StockSEC:0001209191-21-035717:0
11 of 11 declarations
About Sigal Charles Elliott
Sigal Charles Elliott is Administrateur at Vir Biotechnology, Inc., ALNYLAM PHARMACEUTICALS, INC. and Surface Oncology, Inc. The file shows 11 filings in total, and across the 11 sampled filings from 2021-05-25 to 2026-05-22, buys total EUR 172474 and sells total EUR 0, with Attribution as the most common transaction nature.
